Subscribe

Angela Genge, MD, FRCPC, eMBA

Articles by Angela Genge, MD, FRCPC, eMBA

Angela Genge, MD, FRCPC, eMBA, on Targeting STMN2 to Rescue Neurons in ALS

Angela Genge, MD, FRCPC, eMBA, on Targeting STMN2 to Rescue Neurons in ALS

ByAngela Genge, MD, FRCPC, eMBA

March 21st 2023

The chief medical officer of QurAlis discussed the antisense oligonucleotide therapy QRL-201.

Latest Updated Articles

Trending on CGTlive®

Sarepta Therapeutics’ Limb-Girdle Muscular Dystrophy Gene Therapy SRP-9003 Produces “Robust Expression” of β-SG in Phase 3 Trial

AAVantgarde’s Stargardt Gene Therapy AAVB-039 Garners FDA Orphan Drug Designation, Cleared for Trial in UK

© 2025 MJH Life Sciences^®

All rights reserved.